z-logo
open-access-imgOpen Access
MANAGEMENT OF GLOBUS HYSTERICUSAND ROLE OF ANTIDEPRESSANTS
Author(s) -
Seema Batool Shah,
Raja Salman Khurshid,
Altaf Ahmad Malla
Publication year - 2022
Publication title -
international journal of advanced research
Language(s) - English
Resource type - Journals
ISSN - 2320-5407
DOI - 10.21474/ijar01/14334
Subject(s) - esomeprazole , domperidone , medicine , prokinetic agent , fluoxetine , guideline , prospective cohort study , antidepressant , serotonin , receptor , pathology , hippocampus , dopamine
Objective/Hypothesis: To study the treatment response of Globus pharyngeus to ppi/prokinetic combination, and the role of antidepressants in non-responders. The purpose of this study is to devise a guideline for managing Globus pharyngeus which otherwise is a poorly understood and managed condition. Study design: It is a prospective non-randomised study where OPD visiting patients have been followed over a course of 6 to 12 months. Methods: 54 patients of Globus pharyngeus diagnosed, with any organic condition ruled out, were put on esomeprazole-domperidone/levosulpride combination. Patients were followed over 3 weeks and 6 weeks period. The non-reponders were put on antidepressant fluoxetine in addition. The response was again gauged at 6 weeks and 12 weeks. Results: 11 patients responded fairly well to the initial treatment of esomeprazole-domperidone/levosulpride. Rest of the 43 patients were put on Fluoxetine in addition and followed over 6 weeks and 12 weeks time. Out of them, 29 patients responded to a varied extent and the remaining either did not respond or were lost to follow-up. Conclusion: Only a minority of the Globus pharyngeus patients seem to respond to acid suppressant/prokinetic agents. Involvement of a psychiatrist early in the care of these patients is recommended as quite a number of non-responders to the routine treatment do well if managed with anitidepressants as well pointing to the underlying mood ailments.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here